Trial Profile
The Treatment of One or Two Supratentorial Brain Metastases With Surgical Resection and BCNU-Polymer Wafers [carmustine polifeprosan-20 wafer]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary)
- Indications Brain cancer
- Focus Therapeutic Use
- 05 Aug 2008 New trial record.